Clinical Trial Update: A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects

View source ↗

Summary

This is a completed Phase 4 cross-sectional study evaluating bone mineral density in individuals infected with HIV-1, sponsored by Gilead Sciences.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Status: COMPLETED